Aptus Pharma (BOM:544529) Total Equity: ₹233.5 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544529 Aptus Pharma Ltd BOM:544529
18 GF Score
Price ₹269.50
! 6 Warning Signs
View Full Analysis

What is Aptus Pharma Total Equity?

Aptus Pharma BOM:544529 +3.63% 18 Total Equity is ₹233.5 Mil as of Mar. 2026. GuruFocus rates BOM:544529 with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Aptus Pharma's total equity for the quarter that ended in Mar. 2026 was ₹233.5 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Aptus Pharma Total Equity Historical Data

* Premium members only.

The historical data trend for Aptus Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aptus Pharma Total Equity Chart

Aptus Pharma Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Total Equity
9.68 17.67 69.66 233.46

Aptus Pharma Semi-Annual Data
Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Equity Get a 7-Day Free Trial 17.67 0.00 69.66 217.02 233.46
BOM:544529
18GF Score
Aptus Pharma Ltd BOM:544529
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aptus Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Aptus Pharma's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=435.348-201.886
=233.5

Aptus Pharma's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=435.348-201.886
=233.5

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹233.5 Mil mean?
Aptus Pharma (BOM:544529) has a Total Equity of ₹233.5 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Aptus Pharma and its competitors.
Is Aptus Pharma's Total Equity too high?
Aptus Pharma's current Total Equity is ₹233.5 Mil. Overall, Aptus Pharma has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Aptus Pharma's Total Equity compare to MCK and COR?
Aptus Pharma's Total Equity of ₹233.5 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Aptus Pharma and its competitors. Aptus Pharma's current Total Equity is ₹233.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aptus Pharma stock overvalued right now?
Aptus Pharma (BOM:544529) has a current Total Equity of ₹233.5 Mil. The current Total Equity is ₹233.5 Mil. Aptus Pharma's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Aptus Pharma (BOM:544529), the current Total Equity is ₹233.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aptus Pharma Business Description

Address Narayan Nagar, Kalawad Road, SHREE Building, 1st Floor, Opp Satyasai Heart Hospital, Sau Uni Area, Rajkot, GJ, IND, 360005
Aptus Pharma Ltd is engaged in the business of marketing and distribution of finished pharmaceutical formulations. It operates through a contract manufacturing model. The group provides a diverse range of pharmaceutical products catering to various therapeutic categories, including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
18GF Score

Get the complete analysis for BOM:544529

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹269.50
Price